Financial reports
ARS
2023 FY
Annual report to shareholders
24 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
29 Mar 22
Current reports
8-K
Dyadic Reports 2023 Full Year Results and Recent Company Progress
28 Mar 24
8-K
Dyadic Announces Closing of Private Placement of
11 Mar 24
8-K
Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
8 Nov 23
8-K
Other Events
6 Oct 23
8-K
Termination of a Material Definitive Agreement
6 Oct 23
8-K
Dyadic Announces Development and License Agreement to Commercialize Animal-Free Alternative Proteins Using DapibusTM
19 Sep 23
8-K
Dyadic Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
9 Aug 23
8-K/A
Submission of Matters to a Vote of Security Holders
15 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 23
8-K
Dyadic Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
10 May 23
Registration and prospectus
S-3
Shelf registration
24 Apr 24
S-3
Shelf registration
9 Aug 23
S-8
Registration of securities for employees
12 Aug 21
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Aug 21
S-3
Shelf registration
13 Aug 20
S-8
Registration of securities for employees
23 May 19
8-A12B
Registration of securities on exchange
12 Apr 19
10-12G/A
Registration of securities (amended)
8 Feb 19
10-12G
Registration of securities
14 Jan 19
RW
Registration withdrawal request
2 Jan 19
Proxies
DEFA14A
Additional proxy soliciting materials
24 Apr 24
DEF 14A
Definitive proxy
24 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
DEFA14A
Additional proxy soliciting materials
27 Apr 21
DEF 14A
Definitive proxy
27 Apr 21
DEF 14A
Definitive proxy
13 May 20
DEFA14A
Additional proxy soliciting materials
12 May 20
Other
EFFECT
Notice of effectiveness
28 Aug 23
CORRESP
Correspondence with SEC
23 Aug 23
UPLOAD
Letter from SEC
10 Aug 23
EFFECT
Notice of effectiveness
26 Aug 20
UPLOAD
Letter from SEC
21 Aug 20
CORRESP
Correspondence with SEC
21 Aug 20
CERT
Certification of approval for exchange listing
16 Apr 19
SEC STAFF ACTION
SEC staff action: Order
26 Feb 19
CT ORDER
Confidential treatment order
14 Feb 19
CORRESP
Correspondence with SEC
12 Feb 19
Ownership
4
Patrick K. Lucy
15 Apr 24
4
Michael P. Tarnok
15 Apr 24
4
Joseph P Hazelton
15 Apr 24
4
Joseph P Hazelton
15 Apr 24
4
MARK A EMALFARB
15 Apr 24
4
Ping Wang Rawson
15 Apr 24
4
RONEN TCHELET
15 Apr 24
SC 13G/A
Bandera Partners LLC
13 Feb 24
SC 13G/A
Francisco Trust under agreement dated February 28, 1996
1 Feb 24
4
Arindam Bose
4 Jan 24